Pharma.Aero announces Cold Jet and Biocair as the latest additions to the cross-industry collaboration platform of over 50 life science and MedTech stakeholders worldwide.

Frank Van Gelder, Secretary General of Pharma.Aero, welcomes the organization’s newest associate partners: "The continuous pace of member growth underlines the need for the neutral and collaborative platform Pharma.Aero represents, to monitor, discuss and eventually solve the challenges the industry faces in relation to life science logistics. It is the variety of specialized service and product providers together with the life science manufacturing industry, that provides Pharma.Aero and all the members, the perfect cocktail for a true industry cross-pollination, the foundation for walking the talk and create content."

Jan Cloots, Chief Commercial Officer of Cold Jet, envisions the new partnership as an essential link in the company’s strategic approach of the life science industry:

"Cold Jet is thrilled to join the collaborative platform of Pharma.Aero. In my personal belief and passion for supporting the success of future therapies, we are driven by the creation of reliable and sustainable solutions to address the challenges in this industry. Cold Jet is the market leader in Dry Ice Technology with a strong R&D focus and global service, something that is indispensable in ensuring product quality to the final customer, the patient. The link with Pharma.Aero will further enlarge insights and knowledge in order to support and strengthen our strategic investments in the Life Science industries," added Cloots.

Michael De Beuckelaer, Business Development Manager at Biocair, is eager to contribute to innovative projects within the partnership:

“Biocair’s vision of thinking forward and Pharma.Aero’s insights will bring contributions to new innovative solutions. Biocair will also provide their input in the projects from Pharma.Aero making it possible for Biocair to be on the front line of innovating the new pharmaceutical supply chain.”